Sundowning Syndrome: Etiology And Treatment An Escalation Research Paper

PAGES
4
WORDS
1277
Cite

Sundowning Syndrome: Etiology and Treatment An escalation in disruptive behaviors in the late afternoon and early evening among institutionalized patients suffering from dementia and Alzheimer's disease has been a recognized phenomenon for over 60 years (Bachman & Rabins, 2006). The timing of the onset of disruptive behaviors has led to calling this phenomenon sundowning, sundowning syndrome, and nocturnal delirium. Symptoms traditionally associated with sundowning include increased motor activity, confusion, yelling, aggression, wandering, agitation, and anxiety (Scarmeas et al., 2007). In spite of this long history, and a general consensus among clinicians and medical textbooks that sundowning is real, there is still a substantial amount of controversy among researchers whether it's more illusion than fact.

The controversy is due in part to the lack of a consensus definition for sundowning. Cohen-Mansfield (2007) cites three different definitions in order to highlight this lack of consensus: (1) "a syndrome of recurring confusion and increasing levels of agitation, which coincide with the onset of late afternoon and early evening," (2) "the onset or exacerbation of delirium during the evening or night, with improvement or disappearance of delirium during the day," and (3) "an exacerbation or appearance of symptoms indicating increased arousal or impairment in late afternoon, evening or at night among elderly, demented individuals" (p. 396). These definitions reveal some of the discrepancies that continue to plague this area of research, including whether to include nighttime episodes, which symptoms fit under sundowning, and whether dementia is a prerequisite. These conceptual differences manifest themselves in various ways as sundowning research progresses, thus prolonging the controversy (Bachman & Rabins, 2006).

In an attempt to create a more solid foundation for future sundowning studies, a group of researchers from multiple institutions conducted a large Alzheimer's follow-up study spanning a 20-year period (Scarmeas et al., 2007). Of the almost 500 patients in the study, approximately 50% exhibited the symptoms of sundowning at some point during...

...

This represented 60% of all patients who engaged in disruptive behavior during the study period. The likelihood that patients would exhibit disruptive behavior during any time of the day increased 7% (p < 0.001) for each year they suffered from the disease. When adjusted for an array of confounders, sundowning was a significant predictor of cognitive decline, but not mortality, institutionalization, or functional decline. Sundowning, as defined by this study, therefore afflicts 50% of all Alzheimer's patients at during the course of their disease.
Sundowning Etiology

There are many theories that attempt to explain the cause of sundowning syndrome, including both psychological and physical. The psychological theories include exacerbated feelings of social isolation or a nonspecific unmet need (Bachman & Rabins, 2006). On the physical side there has been considerable attention paid to the possible role of circadian rhythms and the main circadian clock, the suprachaismatic nucleus (SCN). Patients with early stages of dementia or Alzheimer's frequently have fragmented sleep-wake cycles that are defined by nocturnal awakenings and daytime naps, and when SCNs from Alzheimer patients were examined post-mortem, signs of pathology were evident (reviewed in: Volicer, Harper, Manning, Goldstein, & Satlin, 2001).

Evidence supporting the role of SCN pathology in sundowning was revealed by a study examining shifts in the daily peaks of core body temperature and motor activity, both accepted markers for circadian rhythm (Volicer et al., 2001). The Alzheimer's patients were divided into three groups for the purpose of the study; patients who engaged in sundowning behavior frequently, sometimes, or rarely. A control group was also included that consisted of elderly patients with no evidence of neurological or psychiatric disease. Patients who engaged in sundowning behaviors frequently reached their peak core temperature an average of 3 hours later than the controls and 2 hours later than the other Alzheimer's patients. The peak in motor activity was reached 3-1/2 hours later for patients who rarely or sometimes engaged in sundowning…

Sources Used in Documents:

4. Sterniczuk, R., Dyck, R.H., LaFerla, F.M., & Antle, M.C. (2010). Characterization of the 3 xTg-AD mouse model of Alzheimer's disease: Part 1. Circadian changes. Brain Research, 1348, 139-148

5. Scarmeas, N., Brandt, J., Blacker, D., Albert, M., Hadjigeorgiou, G., Dubois, B., . . . Stern, Y. (2007). Disruptive behavior as a predictor in Alzheimer's disease. Archives of Neurology, 64, 1755-1761

6. Vance, D.E. & Cowan, R.N. (2004). Activity therapy as a vehicle for resetting the biological rhythm in adults with Alzheimer's disease. Activities, Adaptation & Aging, 28, 1-16


Cite this Document:

"Sundowning Syndrome Etiology And Treatment An Escalation" (2010, November 30) Retrieved April 19, 2024, from
https://www.paperdue.com/essay/sundowning-syndrome-etiology-and-treatment-83898

"Sundowning Syndrome Etiology And Treatment An Escalation" 30 November 2010. Web.19 April. 2024. <
https://www.paperdue.com/essay/sundowning-syndrome-etiology-and-treatment-83898>

"Sundowning Syndrome Etiology And Treatment An Escalation", 30 November 2010, Accessed.19 April. 2024,
https://www.paperdue.com/essay/sundowning-syndrome-etiology-and-treatment-83898

Related Documents
Alzheimer's Disease
PAGES 10 WORDS 3266

ALZHEIMER'S DISEASE Examining the potential use of beta secretase enzymes in the treatment of Alzheimer's Disease Examining the potential use of beta secretase enzymes in the treatment of Alzheimer's Disease Efforts to develop a drug for Alzheimer's disease, which mostly affect people in older age, have not been successful. Instead, most of the treatments offered often target the behavioral symptoms of the affected individual, but not the cause of the disease. The occurrence

Alzheimer Healthy Community PLANNED, PERSONALIZED CARE Alzheimer's Healthy Community Dog-Assisted Therapy for Older People with Dementia A review of nine studies on the subject produced loose conclusions on the value of this type of therapy (Perkins et al., 2008). They, however, established a trend, indicating increased social behavior and decreased agitation when dogs were in the company of the respondents. This improvement in social behavior was unrelated with the severity of the respondents' dementia.

What is worth noting here is the fact that behavior disturbances, ranging in severity from repeated questioning to physical violence, are common (National Institute of Mental Health, 1989). It is unclear whether Alzheimer's disease represents a single entity or several variants. Some experts believe that there are distinct subtypes of Alzheimer's disease, such as Lewy body disease (in which the signs of Parkinson's disease, visual hallucinations or alterations in alertness

Some treatments may actually help with the disease. Diets and dietary supplements Eating vegetables like broccoli and spinach may help older women [and probably men] retain some memory abilities later on, while avoiding obesity in middle age lowers the risk of later Alzheimer's disease in both sexes, new studies suggest." The effect of the vegetables probably comes from the antioxidants and B. vitamins they contain (Ritter, 2004). Herbal remedies and other dietary

Alzheimer's Disease currently affects more than four million Americans. Alzheimer's is a disease characterized by the progressive degeneration of areas within the brain, resulting in cognitive and physical decline that will eventually lead to death. It is important to emphasize that Alzheimer's disease (AD) is not a normal part of aging. Although AD typically appears in those over sixty-five, it is a neurodegenerative disease, quite distinct from any aging-related cognitive

Scientists are racing to find a cure as millions of people reach the age when Alzheimer's is most commonly manifested (Plontz). Experts are still trying to fully understand the cause or causes of Alzheimer's disease. In the meantime, it's helpful to understand the hallmarks of Alzheimer's -- plaques and tangles -- and the risk factors that affect a person's likelihood of developing the disease (Hill). Alzheimer's disease is characterized by a